A Study of Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)
Clinical trial NCT04200365 · TERMINATED
Trial details
- NCT number
- NCT04200365
- Sponsor
- SCRI Development Innovations, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-05
- Primary completion
- 2023-09-07
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.